Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Taking steps now to streamline approval processes for fast-moving diseases will better prepare IRBs to handle not just the current H1N1 virus, but future viruses as well, says Raphael Saginur, MD, FRCPC, chief of the infectious disease division and chairman of the research ethics board (REB) at Ottawa Hospital in Ontario.

Prepare your IRB now for disease outbreaks